1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-di(phenyl)pyrrolidin-2-one;1-ethyl-4-(2-morpholinoethyl)-3,3-di(phenyl)pyrrolidin-2-one;1-ethyl-4-(2-morpholinoethyl)-3,3-di(phenyl)-2-pyrrolidinone;1-ethyl-4-(2-morpholinoethyl)-3,3-di(phenyl)-2-pyrrolidone;309-29-5;1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-di(phenyl)pyrrolidin-2-one;2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-;1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone;2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-;2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl- (9CI);2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-;BRN 0628691;DOXAPRAM;Doxapramum [INN-Latin];EINECS 206-216-3;HSDB 3318;BB_SC-5080;Oprea1_016788;1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-di(phenyl)pyrrolidin-2-one